Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 106 participants.
Also called NCT07048808
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 106 participants
- Sponsor
- XyloCor Therapeutics, Inc.
- Registry
-
NCT07048808
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07048808. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-08 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
- Acronym
- EXACT2
- Condition
- Refractory Angina
- Condition
- Coronary Artery Disease
- Intervention (Combination product)
- XC001
- Intervention (Combination product)
- Sham (No Treatment)
- Lead sponsor
- XyloCor Therapeutics, Inc.
Record details
- Record id
cardio:ct-nct07048808- Content hash
afc3407db2829d55951461556359ba52201f41675ff300b92c742dcf56cc8f5e